Focused Ultrasound Reduces Alcohol Preference and Anxiety in Mice

Neuromodulation Strategies for Chronic Alcohol Addiction

Alcohol use disorder remains a significant clinical challenge, characterized by chronic relapsing patterns driven by deep-seated neurobiological adaptations in reward and emotional processing circuits [1]. While traditional pharmacological and behavioral interventions are the standard of care, many patients continue to struggle with withdrawal-associated anxiety and persistent cravings [2]. Recent advances in neuromodulation, such as deep brain stimulation, have shown that targeting specific dysfunctional networks can alter pathological activity, though these methods often require invasive surgical procedures [3]. Non-invasive alternatives like low-intensity focused ultrasound are now being investigated for their ability to precisely modulate deep brain structures without the risks of surgery [4, 5]. A new study now investigates how this technology might address the specific hippocampal injuries associated with long-term alcohol exposure.

Targeting the Hippocampal Circuit in Alcohol Use Disorder

Alcohol addiction is clinically defined as a chronic relapsing brain disorder characterized by significant neurobiological changes, particularly within the hippocampus. This brain region is of paramount importance to clinicians because it mediates emotional regulation and reward-seeking behavior, the two primary drivers of patient relapse and treatment failure. In this study, researchers utilized a cohort of 26 male C57BL/6 mice, with 20 mice subjected to a 28-day alcohol exposure modeling period to simulate chronic dependency, while 6 mice served as a control group. The study focused on the hippocampus because its structural integrity is essential for maintaining the cognitive and emotional control necessary for long-term sobriety. The researchers identified that alcohol-induced neuronal injury contributes to withdrawal-associated anxiety and persistent alcohol preference, symptoms that often present as major barriers during the detoxification phase. Histological analysis using hematoxylin and eosin staining (a laboratory method used to visualize tissue structure and cell health) revealed that chronic alcohol exposure led to pronounced degeneration and apoptosis (programmed cell death) of granule cells in the dentate gyrus region of the hippocampus. The dentate gyrus is a critical subregion for neurogenesis and memory formation, and its impairment is often linked to the cognitive deficits seen in chronic drinkers. These structural deficits correlate with the behavioral symptoms of addiction, suggesting that the physical degradation of hippocampal circuits is a primary driver of the intense cravings and emotional dysregulation observed in clinical populations. By addressing these specific neurobiological changes, the study aims to mitigate the underlying pathology that fuels the cycle of addiction.

Low-Intensity Focused Ultrasound Protocol and Study Design

To evaluate the potential of non-invasive neuromodulation in treating dependency, the researchers utilized a cohort of 26 male C57BL/6 mice. The experimental design began with a 28-day modeling period during which 20 mice were subjected to chronic alcohol exposure to establish a baseline of addiction and withdrawal pathology, while the remaining 6 mice were maintained as a control group. This prolonged exposure period was designed to induce the neurobiological adaptations and hippocampal damage characteristic of long-term alcohol use disorder. Following the completion of the modeling phase, the alcohol-exposed cohort was randomly subdivided into two distinct arms: a therapy group and a sham group, allowing for a controlled comparison of the intervention's efficacy. The primary intervention involved the application of low-intensity focused ultrasound (LIFU), a technology that delivers mechanical energy to specific subcortical targets without the need for surgical entry. The therapy group received active low-intensity focused ultrasound (LIFU) treatment specifically targeting the hippocampus, a region critical for emotional regulation. In contrast, the sham group underwent an identical procedural setup, but the ultrasound transducer remained powered off, ensuring that any observed effects were due to the ultrasonic waves rather than the handling or environment. This treatment duration lasted seven days, providing a window to observe the immediate effects of neuromodulation on withdrawal symptoms and neuronal recovery. By comparing these groups, the study sought to determine if targeted ultrasonic stimulation could mitigate the cellular degeneration and behavioral cravings induced during the initial 28-day alcohol exposure.

Behavioral Improvements and Anxiety Reduction

Following the completion of the seven day treatment period, the researchers observed distinct behavioral differences between the two experimental arms. The therapy group exhibited less severe anxiety symptoms upon alcohol withdrawal compared to the sham group, suggesting that the application of low-intensity focused ultrasound may stabilize the emotional dysregulation typically seen during the cessation of chronic alcohol intake. This reduction in anxiety is clinically relevant as withdrawal-induced distress is a primary driver of relapse in patients with alcohol use disorder. In addition to the mitigation of withdrawal symptoms, the intervention appeared to influence the underlying drive for alcohol consumption. The therapy group showed a reduced preference for alcohol compared to the sham group, a finding that correlates with the observed preservation of hippocampal integrity. Histological analysis using hematoxylin and eosin staining of the hippocampus revealed that the sham group had more pronounced degeneration and apoptosis (programmed cell death) of granule cells in the dentate gyrus region than the therapy group. Furthermore, the concentration of brain-derived neurotrophic factor (a protein that supports the survival and growth of neurons) was significantly lower in the therapy group than in the sham group, returning to levels that did not differ significantly from the control group. These results indicate that the behavioral improvements in anxiety and alcohol seeking are likely linked to the mitigation of neuronal injury within the dentate gyrus, raising the prospect that future diagnostic tools could match patients to targeted interventions based on their neurobiological profile.

Mitigation of Neuronal Degeneration and BDNF Modulation

The structural impact of low-intensity focused ultrasound on the hippocampal formation was evaluated using hematoxylin and eosin (HE) staining, a histological technique used to visualize tissue morphology and cellular integrity. In the 26 male C57BL/6 mice studied, the researchers observed that the sham group exhibited more pronounced degeneration and apoptosis (programmed cell death) of granule cells in the dentate gyrus (DG) region relative to the therapy group. This localized preservation of the dentate gyrus is clinically significant, as this region is a primary site of neurogenesis and plays a critical role in the regulation of emotional responses and reward processing. The reduction in cellular injury suggests that the mechanical or thermal effects of low-intensity focused ultrasound may provide a neuroprotective buffer against the toxic effects of chronic alcohol exposure. Biochemical analysis further supported these histological findings by measuring the levels of brain-derived neurotrophic factor (BDNF), a protein that supports the survival of existing neurons and encourages the growth and differentiation of new neurons and synapses. The researchers found that the BDNF concentration was significantly lower in the therapy group than in the sham group. While elevated BDNF is often associated with neuroplasticity, in the context of alcohol withdrawal, it can reflect a maladaptive compensatory response to neuronal stress or injury. Notably, the BDNF concentration in the therapy group did not differ significantly from the control group, suggesting that the intervention effectively normalized this protein's expression to baseline levels. These preliminary findings suggest that low-intensity focused ultrasound may modulate alcohol addiction by mitigating hippocampal neuronal injury, potentially stabilizing the neural circuits that drive withdrawal-associated anxiety and the subsequent drive for alcohol consumption. By addressing the underlying structural damage within the hippocampus, this modality offers a potential pathway for treating the neurobiological roots of substance use disorders. The ability to normalize BDNF levels and reduce apoptosis in the dentate gyrus indicates that the behavioral improvements observed in the mice are likely the result of restored hippocampal integrity. For clinicians, these data provide a biological rationale for the use of non-invasive neuromodulation to target specific brain regions involved in the cycle of addiction and relapse.

References

1. Vasconcelos M, Stein DJ, Almeida RMMD. Social defeat protocol and relevant biomarkers, implications for stress response physiology, drug abuse, mood disorders and individual stress vulnerability: a systematic review of the last decade. Trends in Psychiatry and Psychotherapy. 2015. doi:10.1590/2237-6089-2014-0034

2. Dowell D, Ragan K, Jones CM, Baldwin G, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain—United States, 2022. MMWR Recommendations and Reports. 2022. doi:10.15585/mmwr.rr7103a1

3. Zhang KK, Matin R, Gorodetsky C, Ibrahim GM, Gouveia FV. Systematic review of rodent studies of deep brain stimulation for the treatment of neurological, developmental and neuropsychiatric disorders. Translational Psychiatry. 2024. doi:10.1038/s41398-023-02727-5

4. Xu H, Yi Y, Xue C, Guo Z, Li J, Jia J. The efficacy and mechanisms of low-intensity transcranial ultrasound stimulation on pain: a systematic review of human and animal studies. The Journal of Headache and Pain. 2025. doi:10.1186/s10194-025-02096-y

5. Mahoney JJ, Haut MW, Carpenter J, et al. Low-intensity focused ultrasound targeting the nucleus accumbens as a potential treatment for substance use disorder: safety and feasibility clinical trial. Frontiers in Psychiatry. 2023. doi:10.3389/fpsyt.2023.1211566